CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $62,105
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | SCARLETT JOHN A Chairman, President and CEO | Purchase | +12,500 | $1.77 | $22K | 12,500 |
| 2025-02-18 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Stock Option (right to buy) | +2,457,000 | 2,457,000 | ||
| 2025-02-18 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Restricted Stock Units | +410,000 | 410,000 | ||
| 2024-06-06 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2024-06-04 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +600,000 | $2.54 | $1.5M | 600,000 |
| 2024-06-04 | SCARLETT JOHN A Chairman, President and CEO | Sale | −600,000 | $4.00 | $2.4M | 600,000 |
| 2024-06-04 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Stock Option (right to buy) | −600,000 | 0 | ||
| 2024-02-14 | SCARLETT JOHN A CHAIRMAN, PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +3,000,000 | 3,000,000 | ||
| 2023-08-15 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +500,000 | 500,000 | ||
| 2023-02-22 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +1,750,000 | 1,750,000 | ||
| 2023-02-10 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +446,668 | $1.50 | $670K | 446,668 |
| 2023-02-10 | SCARLETT JOHN A Chairman, President and CEO | Sale | −446,668 | $3.00 | $1.3M | 0 |
| 2023-02-10 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Employee Stock Option (right to buy) | −446,668 | 0 | ||
| 2023-02-09 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +446,666 | $1.50 | $670K | 446,666 |
| 2023-02-09 | SCARLETT JOHN A Chairman, President and CEO | Sale | −446,666 | $3.03 | $1.4M | 0 |
| 2023-02-09 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Employee Stock Option (right to buy) | −446,666 | 0 | ||
| 2023-02-08 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +446,666 | $1.50 | $670K | 446,666 |
| 2023-02-08 | SCARLETT JOHN A Chairman, President and CEO | Sale | −446,666 | $3.08 | $1.4M | 0 |
| 2023-02-08 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Employee Stock Option (right to buy) | −446,666 | 0 | ||
| 2022-02-16 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +2,100,000 | 2,100,000 |
Page 1 of 2 · 23 trades